BrandLaunchX is an AI-first launch impact navigation and orchestration platform for biotech and pharmaceutical commercialization, led by executives with direct experience in launch complexity, enterprise decision-making, and life sciences commercialization.
The team combines biotech, pharma and AI strategy, product leadership, enterprise technology, combined with the delivery discipline and executional grip to help organizations navigate biotech brand launch and pharma go-to-market activation with greater foresight, control, and confidence.
Built by leaders who understand how launch risk can manifest and multiply across commercial, access, governance, and execution.
The team are steeped in a practical operating view of life sciences commercialization. Their focus is on building and refining the launch infrastructure that today’s novel therapeutic launches demand.
Being able to discern the right signals from the background noise and to make timely and smart decisions is what drives our clients and our R&D and product teams.
BrandLaunchX brings together leaders across biopharma strategy, product, technology, and market execution. Our team have direct experience of biotech or pharma launches, life sciences commercialization, and enterprise operating discipline.
Our focus is deliberate: strong category judgment, practical execution insight, and the ability to support regulated teams navigating high-stakes launch decisions.
We understand the unique commercial and structural pressures at play, and support this with expertise in platform design and enterprise accountability in regulated life sciences environments.
Abhijit brings more than 30 years of leadership experience across global pharmaceutical organizations, including senior roles at Novartis and AstraZeneca. He founded BrandLaunchX around a clear conviction: scientific approval alone does not secure market impact or patient access.
Steve has held executive and board-level leadership roles across private and publicly held regulated enterprises over the last four decades. He is a global brand and commercial marketing specialist.
Ankitash has architected and deployed enterprise technology platforms for eight of the world’s top ten pharmaceutical companies. His role ensures BLX is designed for secure, compliant, scalable use in complex regulated environments.
Debashish brings more than 25 years of experience spanning artificial intelligence, clinical systems, and global industry standards across multiple Fortune 500 organizations. He connects product strategy with practical life sciences use cases.
Operational delivery is further reinforced by Mohit Jain, Global Delivery Head. Mohit’s background includes leading global delivery and operations teams across Roche, Pfizer, and Novartis, focusing on consistent execution, operational rigour, and high-quality delivery across international biopharma programmes.
Find out more
Collectively, the BrandLaunchX team has supported dozens of global drug launches, worked within top-tier pharmaceutical organisations, and built scalable technology platforms used across international markets. With operations spanning the UK, United States, and India, we combine strategic oversight with execution excellence.
We support biotech and pharma companies in closing the commercialization gap and delivering life-changing therapies to patients faster, more reliably, and at greater scale.
Commercial strategy, launch execution, and market entry experience across large pharmaceutical and biopharma environments.
Global delivery, programme rigour, and cross-functional coordination capabilities that support disciplined execution under pressure.
Enterprise-grade thinking around compliance, accountability, and decision structure for regulated launch environments.
The team understands how market access, portfolio choices, product design, and delivery execution converge in real pharma go-to-market decisions.
We have built a leadership function dedicated to supporting our clients by helping to deliver foresight, control, confidence, and effective launch performance, rather than retrospective reports and theoretical strategy decks.
BrandLaunchX was created in response to very personal loss, and it is driven by a deeply held conviction that where the science has succeeded in providing effective therapies, the commercial and operational launch apparatus must also succeed. By de-risking, accelerating and maximising novel therapeutic launches, BrandLaunchX is on a mission to improve outcomes for all.
Contact UsIf your organisation is evaluating launch readiness, platform fit, or the operating implications of a complex biotech or pharma go-to-market plan, we invite you to book a short Launch Navigation demonstration call.
If you have any questions or would like to request further information please do contact us directly.
See Contact OptionsIntelligent Launch Impact Navigation is set to establish the new benchmark for launch excellence. As a pioneer in this space we would be delighted to share our insights on this important new category.
Request the BriefingIf you’d like more information on how BrandLaunchX could benefit your organisation, have a look at our short platform guide.
BLX